FindTrial
Sign In

The application of ultra-multiplex targeted pathogen third-generation sequencing combined with bedside rapid pathogen assessment of ROSE in the clinical diagnosis of patients with pulmonary infection

The application of ultra-multiplex targeted pathogen third-generation sequencing combined with bedside rapid pathogen assessment of ROSE in the clinical diagnosis of patients with pulmonary infection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116670
Enrollment
Unknown
Registered
2026-01-13
Start date
2023-06-28
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary infection

Interventions

Observation group of Pulmonary Infection:None

Sponsors

Chifeng Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Over 14 years old; 2.Suspected patient with lung infection;

Exclusion criteria

Exclusion criteria: 1.Conditions not considered by clinicians to be committed to active treatment;

Design outcomes

Primary

MeasureTime frame
Outcome situation;—

Countries

China

Contacts

Public ContactXiaohua Li

Chifeng Municipal Hospital

2598247475@qq.com+86 18704762776

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026